nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—ALB—multiple sclerosis	0.625	1	CbGaD
Fospropofol—Hepatic insufficiency—Azathioprine—multiple sclerosis	0.0252	0.135	CcSEcCtD
Fospropofol—Hepatic insufficiency—Methotrexate—multiple sclerosis	0.0101	0.0542	CcSEcCtD
Fospropofol—Hypoxemia—Methotrexate—multiple sclerosis	0.00781	0.0418	CcSEcCtD
Fospropofol—ALPL—medulla oblongata—multiple sclerosis	0.00701	0.0382	CbGeAlD
Fospropofol—ALPL—midbrain—multiple sclerosis	0.00641	0.0349	CbGeAlD
Fospropofol—ALPL—cerebellum—multiple sclerosis	0.00496	0.027	CbGeAlD
Fospropofol—GABRA6—brainstem—multiple sclerosis	0.00472	0.0257	CbGeAlD
Fospropofol—ALPL—brain—multiple sclerosis	0.00403	0.0219	CbGeAlD
Fospropofol—Hepatic failure—Cladribine—multiple sclerosis	0.00387	0.0207	CcSEcCtD
Fospropofol—Angiopathy—Fingolimod—multiple sclerosis	0.00385	0.0206	CcSEcCtD
Fospropofol—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00382	0.0204	CcSEcCtD
Fospropofol—GABRB2—brainstem—multiple sclerosis	0.00347	0.0189	CbGeAlD
Fospropofol—GABRD—medulla oblongata—multiple sclerosis	0.00344	0.0187	CbGeAlD
Fospropofol—GABRG1—medulla oblongata—multiple sclerosis	0.00331	0.018	CbGeAlD
Fospropofol—Cough—Fingolimod—multiple sclerosis	0.00322	0.0172	CcSEcCtD
Fospropofol—GABRB1—medulla oblongata—multiple sclerosis	0.00321	0.0175	CbGeAlD
Fospropofol—Stinging—Prednisolone—multiple sclerosis	0.00319	0.017	CcSEcCtD
Fospropofol—GABRA2—brainstem—multiple sclerosis	0.00317	0.0173	CbGeAlD
Fospropofol—Hepatic failure—Azathioprine—multiple sclerosis	0.00314	0.0168	CcSEcCtD
Fospropofol—GABRD—midbrain—multiple sclerosis	0.00314	0.0171	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00312	0.0167	CcSEcCtD
Fospropofol—GABRG3—nervous system—multiple sclerosis	0.00312	0.017	CbGeAlD
Fospropofol—GABRA1—brainstem—multiple sclerosis	0.00307	0.0167	CbGeAlD
Fospropofol—GABRG1—midbrain—multiple sclerosis	0.00302	0.0165	CbGeAlD
Fospropofol—GABRG3—central nervous system—multiple sclerosis	0.003	0.0163	CbGeAlD
Fospropofol—Nervous system disorder—Fingolimod—multiple sclerosis	0.00296	0.0158	CcSEcCtD
Fospropofol—GABRG1—spinal cord—multiple sclerosis	0.00295	0.0161	CbGeAlD
Fospropofol—Tingling sensation—Methylprednisolone—multiple sclerosis	0.00295	0.0158	CcSEcCtD
Fospropofol—GABRB1—midbrain—multiple sclerosis	0.00293	0.016	CbGeAlD
Fospropofol—Stinging—Triamcinolone—multiple sclerosis	0.00293	0.0157	CcSEcCtD
Fospropofol—Skin disorder—Fingolimod—multiple sclerosis	0.00293	0.0156	CcSEcCtD
Fospropofol—GABRB1—spinal cord—multiple sclerosis	0.00286	0.0156	CbGeAlD
Fospropofol—Hypotension—Fingolimod—multiple sclerosis	0.00282	0.0151	CcSEcCtD
Fospropofol—Propofol—ALB—multiple sclerosis	0.0028	1	CrCbGaD
Fospropofol—Paraesthesia—Fingolimod—multiple sclerosis	0.00271	0.0145	CcSEcCtD
Fospropofol—Tingling sensation—Betamethasone—multiple sclerosis	0.00268	0.0143	CcSEcCtD
Fospropofol—Tingling sensation—Dexamethasone—multiple sclerosis	0.00268	0.0143	CcSEcCtD
Fospropofol—Stinging—Betamethasone—multiple sclerosis	0.00266	0.0142	CcSEcCtD
Fospropofol—Stinging—Dexamethasone—multiple sclerosis	0.00266	0.0142	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.0026	0.0139	CcSEcCtD
Fospropofol—GABRD—nervous system—multiple sclerosis	0.00258	0.0141	CbGeAlD
Fospropofol—GABRD—central nervous system—multiple sclerosis	0.00249	0.0135	CbGeAlD
Fospropofol—GABRG1—nervous system—multiple sclerosis	0.00249	0.0135	CbGeAlD
Fospropofol—GABRA6—nervous system—multiple sclerosis	0.00247	0.0135	CbGeAlD
Fospropofol—Hypoxia—Methotrexate—multiple sclerosis	0.00247	0.0132	CcSEcCtD
Fospropofol—GABRD—cerebellum—multiple sclerosis	0.00243	0.0132	CbGeAlD
Fospropofol—GABRB2—medulla oblongata—multiple sclerosis	0.00242	0.0132	CbGeAlD
Fospropofol—GABRG2—medulla oblongata—multiple sclerosis	0.00242	0.0132	CbGeAlD
Fospropofol—GABRB1—nervous system—multiple sclerosis	0.00241	0.0131	CbGeAlD
Fospropofol—GABRA5—nervous system—multiple sclerosis	0.0024	0.0131	CbGeAlD
Fospropofol—GABRG1—central nervous system—multiple sclerosis	0.00239	0.013	CbGeAlD
Fospropofol—GABRG3—brain—multiple sclerosis	0.00238	0.013	CbGeAlD
Fospropofol—GABRA6—central nervous system—multiple sclerosis	0.00238	0.013	CbGeAlD
Fospropofol—GABRG1—cerebellum—multiple sclerosis	0.00234	0.0127	CbGeAlD
Fospropofol—GABRA6—cerebellum—multiple sclerosis	0.00233	0.0127	CbGeAlD
Fospropofol—GABRB1—central nervous system—multiple sclerosis	0.00232	0.0126	CbGeAlD
Fospropofol—GABRA5—central nervous system—multiple sclerosis	0.00231	0.0126	CbGeAlD
Fospropofol—GABRB1—cerebellum—multiple sclerosis	0.00227	0.0123	CbGeAlD
Fospropofol—GABRA3—nervous system—multiple sclerosis	0.00223	0.0121	CbGeAlD
Fospropofol—GABRB2—midbrain—multiple sclerosis	0.00221	0.012	CbGeAlD
Fospropofol—GABRG2—midbrain—multiple sclerosis	0.00221	0.012	CbGeAlD
Fospropofol—Angiopathy—Cladribine—multiple sclerosis	0.00218	0.0117	CcSEcCtD
Fospropofol—GABRA4—nervous system—multiple sclerosis	0.00217	0.0118	CbGeAlD
Fospropofol—Mediastinal disorder—Cladribine—multiple sclerosis	0.00217	0.0116	CcSEcCtD
Fospropofol—GABRG2—spinal cord—multiple sclerosis	0.00216	0.0118	CbGeAlD
Fospropofol—GABRB2—spinal cord—multiple sclerosis	0.00216	0.0118	CbGeAlD
Fospropofol—GABRA3—central nervous system—multiple sclerosis	0.00215	0.0117	CbGeAlD
Fospropofol—GABRA1—medulla oblongata—multiple sclerosis	0.00214	0.0116	CbGeAlD
Fospropofol—Pruritus—Fingolimod—multiple sclerosis	0.00213	0.0114	CcSEcCtD
Fospropofol—GABRA4—central nervous system—multiple sclerosis	0.00209	0.0114	CbGeAlD
Fospropofol—GABRA4—cerebellum—multiple sclerosis	0.00205	0.0111	CbGeAlD
Fospropofol—GABRD—brain—multiple sclerosis	0.00197	0.0107	CbGeAlD
Fospropofol—GABRA1—midbrain—multiple sclerosis	0.00195	0.0106	CbGeAlD
Fospropofol—GABRA1—spinal cord—multiple sclerosis	0.00191	0.0104	CbGeAlD
Fospropofol—GABRG1—brain—multiple sclerosis	0.0019	0.0103	CbGeAlD
Fospropofol—GABRA6—brain—multiple sclerosis	0.00189	0.0103	CbGeAlD
Fospropofol—Headache—Fingolimod—multiple sclerosis	0.00189	0.0101	CcSEcCtD
Fospropofol—GABRB3—medulla oblongata—multiple sclerosis	0.00186	0.0101	CbGeAlD
Fospropofol—Apnoea—Methotrexate—multiple sclerosis	0.00185	0.00989	CcSEcCtD
Fospropofol—GABRB1—brain—multiple sclerosis	0.00184	0.01	CbGeAlD
Fospropofol—GABRA5—brain—multiple sclerosis	0.00183	0.00997	CbGeAlD
Fospropofol—Cough—Cladribine—multiple sclerosis	0.00183	0.00976	CcSEcCtD
Fospropofol—GABRG2—nervous system—multiple sclerosis	0.00182	0.0099	CbGeAlD
Fospropofol—GABRB2—nervous system—multiple sclerosis	0.00182	0.0099	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00177	0.00946	CcSEcCtD
Fospropofol—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00176	0.00942	CcSEcCtD
Fospropofol—GABRB2—central nervous system—multiple sclerosis	0.00175	0.00953	CbGeAlD
Fospropofol—GABRG2—central nervous system—multiple sclerosis	0.00175	0.00953	CbGeAlD
Fospropofol—GABRB2—cerebellum—multiple sclerosis	0.00171	0.00932	CbGeAlD
Fospropofol—GABRG2—cerebellum—multiple sclerosis	0.00171	0.00932	CbGeAlD
Fospropofol—GABRA3—brain—multiple sclerosis	0.00171	0.00929	CbGeAlD
Fospropofol—GABRB3—midbrain—multiple sclerosis	0.0017	0.00925	CbGeAlD
Fospropofol—Nervous system disorder—Cladribine—multiple sclerosis	0.00168	0.00895	CcSEcCtD
Fospropofol—GABRA4—brain—multiple sclerosis	0.00166	0.00905	CbGeAlD
Fospropofol—GABRA2—nervous system—multiple sclerosis	0.00166	0.00905	CbGeAlD
Fospropofol—Skin disorder—Cladribine—multiple sclerosis	0.00166	0.00887	CcSEcCtD
Fospropofol—GABRB3—spinal cord—multiple sclerosis	0.00166	0.00903	CbGeAlD
Fospropofol—GABRA1—nervous system—multiple sclerosis	0.00161	0.00874	CbGeAlD
Fospropofol—GABRA2—central nervous system—multiple sclerosis	0.0016	0.00871	CbGeAlD
Fospropofol—Hypotension—Cladribine—multiple sclerosis	0.0016	0.00853	CcSEcCtD
Fospropofol—GABRA2—cerebellum—multiple sclerosis	0.00156	0.00851	CbGeAlD
Fospropofol—GABRA1—central nervous system—multiple sclerosis	0.00155	0.00842	CbGeAlD
Fospropofol—Paraesthesia—Cladribine—multiple sclerosis	0.00153	0.0082	CcSEcCtD
Fospropofol—GABRA1—cerebellum—multiple sclerosis	0.00151	0.00823	CbGeAlD
Fospropofol—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00147	0.00788	CcSEcCtD
Fospropofol—Pain—Cladribine—multiple sclerosis	0.00146	0.00781	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00144	0.00769	CcSEcCtD
Fospropofol—GABRB3—nervous system—multiple sclerosis	0.0014	0.00761	CbGeAlD
Fospropofol—GABRB2—brain—multiple sclerosis	0.00139	0.00757	CbGeAlD
Fospropofol—GABRG2—brain—multiple sclerosis	0.00139	0.00757	CbGeAlD
Fospropofol—Skin disorder—Azathioprine—multiple sclerosis	0.00135	0.00721	CcSEcCtD
Fospropofol—GABRB3—central nervous system—multiple sclerosis	0.00134	0.00732	CbGeAlD
Fospropofol—GABRB3—cerebellum—multiple sclerosis	0.00131	0.00716	CbGeAlD
Fospropofol—Hypotension—Azathioprine—multiple sclerosis	0.0013	0.00694	CcSEcCtD
Fospropofol—GABRA2—brain—multiple sclerosis	0.00127	0.00692	CbGeAlD
Fospropofol—Hepatic failure—Methotrexate—multiple sclerosis	0.00127	0.00677	CcSEcCtD
Fospropofol—GABRA1—brain—multiple sclerosis	0.00123	0.00668	CbGeAlD
Fospropofol—Pruritus—Cladribine—multiple sclerosis	0.00121	0.00646	CcSEcCtD
Fospropofol—Cough—Mitoxantrone—multiple sclerosis	0.0012	0.00642	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.0012	0.00641	CcSEcCtD
Fospropofol—ALB—brain—multiple sclerosis	0.00115	0.00625	CbGeAlD
Fospropofol—Skin disorder—Mitoxantrone—multiple sclerosis	0.00109	0.00583	CcSEcCtD
Fospropofol—Vomiting—Cladribine—multiple sclerosis	0.00109	0.00581	CcSEcCtD
Fospropofol—Angiopathy—Methylprednisolone—multiple sclerosis	0.00108	0.00577	CcSEcCtD
Fospropofol—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00107	0.00573	CcSEcCtD
Fospropofol—Headache—Cladribine—multiple sclerosis	0.00107	0.00572	CcSEcCtD
Fospropofol—GABRB3—brain—multiple sclerosis	0.00107	0.00581	CbGeAlD
Fospropofol—Hypotension—Mitoxantrone—multiple sclerosis	0.00105	0.00561	CcSEcCtD
Fospropofol—Nausea—Cladribine—multiple sclerosis	0.00101	0.00542	CcSEcCtD
Fospropofol—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00101	0.00539	CcSEcCtD
Fospropofol—Angiopathy—Betamethasone—multiple sclerosis	0.000982	0.00525	CcSEcCtD
Fospropofol—Angiopathy—Dexamethasone—multiple sclerosis	0.000982	0.00525	CcSEcCtD
Fospropofol—Pain—Mitoxantrone—multiple sclerosis	0.00096	0.00513	CcSEcCtD
Fospropofol—Cough—Triamcinolone—multiple sclerosis	0.000906	0.00484	CcSEcCtD
Fospropofol—Vomiting—Azathioprine—multiple sclerosis	0.000883	0.00472	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000876	0.00468	CcSEcCtD
Fospropofol—Headache—Azathioprine—multiple sclerosis	0.00087	0.00465	CcSEcCtD
Fospropofol—Angiopathy—Prednisone—multiple sclerosis	0.000855	0.00457	CcSEcCtD
Fospropofol—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000829	0.00443	CcSEcCtD
Fospropofol—Paraesthesia—Prednisolone—multiple sclerosis	0.000827	0.00442	CcSEcCtD
Fospropofol—Nausea—Azathioprine—multiple sclerosis	0.000825	0.00441	CcSEcCtD
Fospropofol—Skin disorder—Methylprednisolone—multiple sclerosis	0.000821	0.00439	CcSEcCtD
Fospropofol—Hypotension—Methylprednisolone—multiple sclerosis	0.00079	0.00422	CcSEcCtD
Fospropofol—Pain—Prednisolone—multiple sclerosis	0.000788	0.00421	CcSEcCtD
Fospropofol—Paraesthesia—Triamcinolone—multiple sclerosis	0.000761	0.00407	CcSEcCtD
Fospropofol—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000759	0.00406	CcSEcCtD
Fospropofol—Nervous system disorder—Betamethasone—multiple sclerosis	0.000754	0.00403	CcSEcCtD
Fospropofol—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000754	0.00403	CcSEcCtD
Fospropofol—Pain—Triamcinolone—multiple sclerosis	0.000724	0.00387	CcSEcCtD
Fospropofol—Hypotension—Dexamethasone—multiple sclerosis	0.000718	0.00384	CcSEcCtD
Fospropofol—Hypotension—Betamethasone—multiple sclerosis	0.000718	0.00384	CcSEcCtD
Fospropofol—Angiopathy—Methotrexate—multiple sclerosis	0.000714	0.00382	CcSEcCtD
Fospropofol—Vomiting—Mitoxantrone—multiple sclerosis	0.000714	0.00382	CcSEcCtD
Fospropofol—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00071	0.00379	CcSEcCtD
Fospropofol—Headache—Mitoxantrone—multiple sclerosis	0.000703	0.00376	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000694	0.00371	CcSEcCtD
Fospropofol—Paraesthesia—Betamethasone—multiple sclerosis	0.00069	0.00369	CcSEcCtD
Fospropofol—Paraesthesia—Dexamethasone—multiple sclerosis	0.00069	0.00369	CcSEcCtD
Fospropofol—Nausea—Mitoxantrone—multiple sclerosis	0.000667	0.00356	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000664	0.00355	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000664	0.00355	CcSEcCtD
Fospropofol—Pain—Betamethasone—multiple sclerosis	0.000657	0.00351	CcSEcCtD
Fospropofol—Pain—Dexamethasone—multiple sclerosis	0.000657	0.00351	CcSEcCtD
Fospropofol—Nervous system disorder—Prednisone—multiple sclerosis	0.000657	0.00351	CcSEcCtD
Fospropofol—Skin disorder—Prednisone—multiple sclerosis	0.00065	0.00348	CcSEcCtD
Fospropofol—Paraesthesia—Prednisone—multiple sclerosis	0.000601	0.00321	CcSEcCtD
Fospropofol—Pruritus—Triamcinolone—multiple sclerosis	0.000599	0.0032	CcSEcCtD
Fospropofol—Cough—Methotrexate—multiple sclerosis	0.000598	0.0032	CcSEcCtD
Fospropofol—Pruritus—Methylprednisolone—multiple sclerosis	0.000598	0.0032	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00058	0.0031	CcSEcCtD
Fospropofol—Headache—Prednisolone—multiple sclerosis	0.000577	0.00308	CcSEcCtD
Fospropofol—Nervous system disorder—Methotrexate—multiple sclerosis	0.000549	0.00293	CcSEcCtD
Fospropofol—Nausea—Prednisolone—multiple sclerosis	0.000547	0.00292	CcSEcCtD
Fospropofol—Pruritus—Dexamethasone—multiple sclerosis	0.000544	0.00291	CcSEcCtD
Fospropofol—Pruritus—Betamethasone—multiple sclerosis	0.000544	0.00291	CcSEcCtD
Fospropofol—Skin disorder—Methotrexate—multiple sclerosis	0.000543	0.0029	CcSEcCtD
Fospropofol—Vomiting—Triamcinolone—multiple sclerosis	0.000539	0.00288	CcSEcCtD
Fospropofol—Vomiting—Methylprednisolone—multiple sclerosis	0.000537	0.00287	CcSEcCtD
Fospropofol—Headache—Triamcinolone—multiple sclerosis	0.000531	0.00284	CcSEcCtD
Fospropofol—Headache—Methylprednisolone—multiple sclerosis	0.00053	0.00283	CcSEcCtD
Fospropofol—Hypotension—Methotrexate—multiple sclerosis	0.000523	0.00279	CcSEcCtD
Fospropofol—Nausea—Triamcinolone—multiple sclerosis	0.000503	0.00269	CcSEcCtD
Fospropofol—Paraesthesia—Methotrexate—multiple sclerosis	0.000502	0.00268	CcSEcCtD
Fospropofol—Nausea—Methylprednisolone—multiple sclerosis	0.000502	0.00268	CcSEcCtD
Fospropofol—Vomiting—Dexamethasone—multiple sclerosis	0.000489	0.00261	CcSEcCtD
Fospropofol—Vomiting—Betamethasone—multiple sclerosis	0.000489	0.00261	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000483	0.00258	CcSEcCtD
Fospropofol—Headache—Dexamethasone—multiple sclerosis	0.000482	0.00257	CcSEcCtD
Fospropofol—Headache—Betamethasone—multiple sclerosis	0.000482	0.00257	CcSEcCtD
Fospropofol—Pain—Methotrexate—multiple sclerosis	0.000478	0.00256	CcSEcCtD
Fospropofol—Pruritus—Prednisone—multiple sclerosis	0.000474	0.00253	CcSEcCtD
Fospropofol—Nausea—Dexamethasone—multiple sclerosis	0.000457	0.00244	CcSEcCtD
Fospropofol—Nausea—Betamethasone—multiple sclerosis	0.000457	0.00244	CcSEcCtD
Fospropofol—Vomiting—Prednisone—multiple sclerosis	0.000426	0.00227	CcSEcCtD
Fospropofol—Headache—Prednisone—multiple sclerosis	0.000419	0.00224	CcSEcCtD
Fospropofol—Nausea—Prednisone—multiple sclerosis	0.000398	0.00213	CcSEcCtD
Fospropofol—Pruritus—Methotrexate—multiple sclerosis	0.000396	0.00212	CcSEcCtD
Fospropofol—Vomiting—Methotrexate—multiple sclerosis	0.000356	0.0019	CcSEcCtD
Fospropofol—Headache—Methotrexate—multiple sclerosis	0.000351	0.00187	CcSEcCtD
Fospropofol—Nausea—Methotrexate—multiple sclerosis	0.000332	0.00178	CcSEcCtD
Fospropofol—ALPL—BDNF signaling pathway—KCNA3—multiple sclerosis	0.00011	0.0926	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—LINGO1—multiple sclerosis	8.77e-05	0.074	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—SPP1—multiple sclerosis	4e-05	0.0338	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—CNR1—multiple sclerosis	2.91e-05	0.0246	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	2.37e-05	0.02	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—BDNF—multiple sclerosis	2.36e-05	0.0199	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—KCNA3—multiple sclerosis	2.23e-05	0.0188	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—MMP9—multiple sclerosis	2.13e-05	0.018	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—SPP1—multiple sclerosis	2.09e-05	0.0176	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—MMP9—multiple sclerosis	2.08e-05	0.0175	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—STAT3—multiple sclerosis	1.85e-05	0.0156	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—LINGO1—multiple sclerosis	1.78e-05	0.015	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—TGFB1—multiple sclerosis	1.75e-05	0.0148	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—MAPK1—multiple sclerosis	1.68e-05	0.0142	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—KCNA3—multiple sclerosis	1.67e-05	0.0141	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—KCNA3—multiple sclerosis	1.65e-05	0.0139	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—KCNA3—multiple sclerosis	1.56e-05	0.0132	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—KCNA3—multiple sclerosis	1.54e-05	0.013	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—KCNA3—multiple sclerosis	1.41e-05	0.0119	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—KCNA3—multiple sclerosis	1.37e-05	0.0116	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—KCNA3—multiple sclerosis	1.34e-05	0.0113	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—KCNA3—multiple sclerosis	1.32e-05	0.0112	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—KCNA3—multiple sclerosis	1.31e-05	0.0111	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—KCNA3—multiple sclerosis	1.29e-05	0.0109	CbGpPWpGaD
Fospropofol—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	1.13e-05	0.00952	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—KCNA3—multiple sclerosis	1.13e-05	0.00951	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—STAT3—multiple sclerosis	9.89e-06	0.00835	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	9.83e-06	0.00829	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—PLEK—multiple sclerosis	9.2e-06	0.00777	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—MAPK1—multiple sclerosis	8.99e-06	0.00759	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	8.77e-06	0.0074	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	7.45e-06	0.00629	CbGpPWpGaD
Fospropofol—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	6.48e-06	0.00547	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.24e-06	0.00527	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.15e-06	0.00519	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	6.13e-06	0.00517	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	6.04e-06	0.0051	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—CNR1—multiple sclerosis	5.92e-06	0.00499	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.82e-06	0.00491	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.74e-06	0.00485	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.71e-06	0.00482	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.64e-06	0.00476	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.25e-06	0.00443	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	5.17e-06	0.00436	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.16e-06	0.00435	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.1e-06	0.00431	CbGpPWpGaD
Fospropofol—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	5.05e-06	0.00426	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—BCHE—multiple sclerosis	5.01e-06	0.00423	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.01e-06	0.00423	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.92e-06	0.00416	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.92e-06	0.00415	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.89e-06	0.00413	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.84e-06	0.00408	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.81e-06	0.00406	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.8e-06	0.00405	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—BDNF—multiple sclerosis	4.79e-06	0.00404	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	4.73e-06	0.00399	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.73e-06	0.00399	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.72e-06	0.00398	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—BCHE—multiple sclerosis	4.7e-06	0.00396	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.66e-06	0.00393	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—BCHE—multiple sclerosis	4.63e-06	0.0039	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.41e-06	0.00372	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—BCHE—multiple sclerosis	4.38e-06	0.00369	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.35e-06	0.00367	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—BCHE—multiple sclerosis	4.32e-06	0.00365	CbGpPWpGaD
Fospropofol—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	4.31e-06	0.00363	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—SPP1—multiple sclerosis	4.25e-06	0.00359	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	4.24e-06	0.00358	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	4.2e-06	0.00354	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.13e-06	0.00348	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	4.08e-06	0.00345	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL4—multiple sclerosis	4.08e-06	0.00344	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	3.98e-06	0.00336	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.98e-06	0.00336	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—BCHE—multiple sclerosis	3.95e-06	0.00334	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.87e-06	0.00326	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	3.85e-06	0.00325	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—BCHE—multiple sclerosis	3.84e-06	0.00324	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.8e-06	0.0032	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—BCHE—multiple sclerosis	3.77e-06	0.00318	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.74e-06	0.00315	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.73e-06	0.00315	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.71e-06	0.00313	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—BCHE—multiple sclerosis	3.71e-06	0.00313	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.68e-06	0.00311	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—BCHE—multiple sclerosis	3.68e-06	0.00311	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	3.68e-06	0.0031	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.64e-06	0.00307	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—BCHE—multiple sclerosis	3.62e-06	0.00305	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	3.59e-06	0.00303	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	3.56e-06	0.00301	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.48e-06	0.00294	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.44e-06	0.0029	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SELPLG—multiple sclerosis	3.41e-06	0.00287	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CD58—multiple sclerosis	3.41e-06	0.00287	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MERTK—multiple sclerosis	3.41e-06	0.00287	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.3e-06	0.00279	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.26e-06	0.00275	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—ICAM1—multiple sclerosis	3.24e-06	0.00273	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.18e-06	0.00269	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—BCHE—multiple sclerosis	3.16e-06	0.00267	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.15e-06	0.00266	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.08e-06	0.0026	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.06e-06	0.00258	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.04e-06	0.00257	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	3.03e-06	0.00256	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3e-06	0.00253	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.95e-06	0.00249	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.93e-06	0.00247	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—CCL2—multiple sclerosis	2.9e-06	0.00245	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.88e-06	0.00243	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.78e-06	0.00235	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.7e-06	0.00228	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	2.7e-06	0.00228	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.65e-06	0.00224	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.61e-06	0.0022	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.59e-06	0.00219	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	2.57e-06	0.00217	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.54e-06	0.00215	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.52e-06	0.00212	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	2.51e-06	0.00211	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IFNG—multiple sclerosis	2.46e-06	0.00208	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	2.4e-06	0.00203	CbGpPWpGaD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.38e-06	0.00201	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.35e-06	0.00198	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.35e-06	0.00198	CbGpPWpGaD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.35e-06	0.00198	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	2.3e-06	0.00194	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.22e-06	0.00188	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.22e-06	0.00187	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL1B—multiple sclerosis	2.2e-06	0.00186	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.19e-06	0.00185	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL2—multiple sclerosis	2.19e-06	0.00185	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLEK—multiple sclerosis	2.1e-06	0.00178	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—STAT3—multiple sclerosis	2.01e-06	0.0017	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	2.01e-06	0.00169	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	1.96e-06	0.00165	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.96e-06	0.00165	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.95e-06	0.00164	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.93e-06	0.00163	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.91e-06	0.00161	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.88e-06	0.00159	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.87e-06	0.00158	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.83e-06	0.00155	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—MAPK1—multiple sclerosis	1.83e-06	0.00154	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	1.82e-06	0.00154	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.79e-06	0.00151	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.76e-06	0.00149	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.75e-06	0.00147	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.67e-06	0.00141	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.65e-06	0.00139	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.6e-06	0.00135	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TNF—multiple sclerosis	1.6e-06	0.00135	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	1.58e-06	0.00134	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.51e-06	0.00127	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SRM—multiple sclerosis	1.49e-06	0.00125	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SELE—multiple sclerosis	1.48e-06	0.00125	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.47e-06	0.00124	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—TGFB1—multiple sclerosis	1.46e-06	0.00124	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.44e-06	0.00122	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.44e-06	0.00121	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	1.42e-06	0.0012	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.41e-06	0.00119	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.4e-06	0.00119	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.4e-06	0.00118	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	1.4e-06	0.00118	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.38e-06	0.00116	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—MAPK1—multiple sclerosis	1.37e-06	0.00116	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—MAPK1—multiple sclerosis	1.35e-06	0.00114	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL6—multiple sclerosis	1.29e-06	0.00109	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—MAPK1—multiple sclerosis	1.28e-06	0.00108	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.27e-06	0.00107	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	1.27e-06	0.00107	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—MAPK1—multiple sclerosis	1.26e-06	0.00107	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.21e-06	0.00102	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.19e-06	0.001	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.17e-06	0.000989	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—MAPK1—multiple sclerosis	1.16e-06	0.000975	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.13e-06	0.000954	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—MAPK1—multiple sclerosis	1.12e-06	0.000947	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.11e-06	0.000936	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—MAPK1—multiple sclerosis	1.1e-06	0.00093	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.1e-06	0.000924	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—MAPK1—multiple sclerosis	1.08e-06	0.000914	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—MAPK1—multiple sclerosis	1.08e-06	0.000908	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITGA4—multiple sclerosis	1.07e-06	0.000905	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNB1—multiple sclerosis	1.06e-06	0.000898	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—MAPK1—multiple sclerosis	1.06e-06	0.000892	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP27B1—multiple sclerosis	1.05e-06	0.000883	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP24A1—multiple sclerosis	1.05e-06	0.000883	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.02e-06	0.000863	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.02e-06	0.000863	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1e-06	0.000845	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.73e-07	0.000821	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPC5—multiple sclerosis	9.57e-07	0.000808	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.55e-07	0.000806	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.39e-07	0.000792	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.33e-07	0.000787	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—MAPK1—multiple sclerosis	9.24e-07	0.000779	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.16e-07	0.000773	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	8.33e-07	0.000703	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	8.01e-07	0.000676	CbGpPWpGaD
Fospropofol—ALB—Metabolism—RRM1—multiple sclerosis	7.93e-07	0.000669	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL2RA—multiple sclerosis	7.32e-07	0.000618	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	6.5e-07	0.000548	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	6.37e-07	0.000538	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	6.15e-07	0.000519	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	5.29e-07	0.000446	CbGpPWpGaD
Fospropofol—ALB—Metabolism—BCHE—multiple sclerosis	4.56e-07	0.000384	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL2—multiple sclerosis	4.29e-07	0.000362	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TGFB1—multiple sclerosis	3.35e-07	0.000283	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—MAPK1—multiple sclerosis	3.28e-07	0.000277	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOE—multiple sclerosis	2.74e-07	0.000231	CbGpPWpGaD
Fospropofol—ALB—Metabolism—POMC—multiple sclerosis	2.35e-07	0.000199	CbGpPWpGaD
